# Walter M. Stadler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/walter-m-stadler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,005 |
| Field | Renal cell carcinoma treatment |
| h-index | 95 |
| i10-index | 359 |
| Last Known Institution | Project HOPE |
| OpenAlex ID | https://openalex.org/A5088131964 |
| ORCID iD | https://orcid.org/0000-0002-0435-2527 |
| Works | 788 |

## Researcher papers

- [Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3](https://scholariq.org/papers/trial-design-and-objectives-for-castration-resistant-prostate-cancer-updated/)
- [Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma](https://scholariq.org/papers/clinical-activity-and-molecular-correlates-of-response-to-atezolizumab-alone-or/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Project HOPE](https://scholariq.org/institutions/project-hope/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.